CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
123I-metaiodobenzylguanidinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01250912
NCT01250912N/ACompleted
CompareCT.gov

Three Dimension Neuron Imaging Using 123I-metaiodobenzylguanidine Single Photon Emission Computed Tomography to Guide Ventricular Tachycardia Ablations

University of Maryland, Baltimore·interventional·Posted Dec 1, 2010·Updated Jan 27, 2022

In Brief

A clinical study evaluating 123I-metaiodobenzylguanidine for Ventricular Tachycardia and Arrhythmia. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Some patients are at risk for life-threatening fast heart rates. These can frequently be treated by using a catheter inside the heart to burn away the cells that create the fast heart rates. The purpose of this study is to image the nerves inside the heart of those patients. The investigators want to find out if abnormalities in the nervous system in the heart can help the physician to find the area that needs to be burnt away.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentricular Tachycardia, Arrhythmia
CountriesUnited States
CollaboratorsGE Healthcare

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 1, 2010
Enrollment StartMar 1, 2010
Primary CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 9.3 yearsPosted 15.6 years ago

Interventions

123I-metaiodobenzylguanidinedrug

FDA Approved for use in Cancer patients. This use is Off Label. For the imaging study, an activity of 370 MBq (10 mCi) 123I-mIBG (GE Healthcare) will be administered intravenously, and a 10-minute planar image of the anterior thorax (128\_128 matrix) will be acquired beginning 15 minutes after tracer injection.